Please try another search
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company’s lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient’s own red blood cells, as well as consists of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising EryKit, Syringe Kit, drugs, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.
Name | Age | Since | Title |
---|---|---|---|
Marwan Sabbagh | - | - | Member of Clinical Advisory Board |
Ted Yednock | 66 | - | Member of Scientific Advisory Board |
Clive Holmes | - | 2020 | Clinical Advisory Board Member |
Margaret A. McLoughlin | 61 | 2015 | Independent Director |
Mathew Bogyo | - | - | Member of Scientific Advisory Board |
Una S. Ryan | 82 | 2019 | Lead Independent Director |
Jeffrey L. Cummings | 74 | 2019 | Member of Clinical Advisory Board |
Eric M. Gordon | - | - | Member of Scientific Advisory Board |
Jan Potempa | - | - | Member of Scientific Advisory Board |
David Munoz | - | - | Member of Clinical Advisory Board |
Ilan Zipkin | - | - | Member of Scientific Advisory Board |
Mark Ryder | - | - | Member of Clinical Advisory Board |
Merce Boada | - | 2020 | Member of Clinical Advisory Board |
Martin Rhys Farlow | - | - | Member of Clinical Advisory Board |
Mark Brody | - | - | Member of Clinical Advisory Board |
Richard C. White | - | - | Member of Scientific Advisory Board |
Christopher J. Senner | 56 | 2019 | Independent Director |
James A. Spudich | 82 | 2024 | Member of Scientific Advisory Board |
Vladimir R. Muzykantov | - | 2024 | Member of Scientific Advisory Board |
Pierre N. Tariot | - | 2019 | Member of Clinical Advisory Board |
David A. Lowe | 77 | - | Member of Scientific Advisory Board |
David A. Lamond | 49 | 2015 | Independent Chairman of the board |
Lon S. Schneider | - | 2019 | Member of Clinical Advisory Board |
June Bray | 69 | 2022 | Independent Director |
Thomas P. Laughren | - | 2019 | Clinical Advisory Board Member |
Carlo Brugnara | - | 2024 | Member of Scientific Advisory Board |
William Jusko | - | 2024 | Member of Scientific Advisory Board |
Howard Lederman | - | 2024 | Member of Scientific Advisory Board |
Susan Perlman | - | 2024 | Member of Scientific Advisory Board |
Mauro Magnani | - | 2024 | Chairman of Scientific Advisory Board |
Rajiv Patni | 55 | 2024 | Independent Director |
Luca Benatti | 63 | 2023 | Independent Director |
Dirk Thye | 54 | 2022 | CEO, Chief Medical Officer & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review